DEF 14AThe Ballot
Kalaris Therapeutics, Inc. files DEF 14A
Filed Mar 31, 2023 · 3y ago · Accession 0001193125-23-088065
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- DEF 14A
- Filing date
- Mar 31, 2023
- Report date
- May 11, 2023
- Document
- d409282ddef14a.htm
- Size
- 845 KB